09.04.2015 Views

o_19iegmggm117sh5d1t7b1m2b1v08a.pdf

This report provides comprehensive information on the current therapeutic developmental pipeline of CoMentis, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. http://www.researchmoz.us/comentis-inc-product-pipeline-review-2015-report.html

This report provides comprehensive information on the current therapeutic developmental pipeline of CoMentis, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

http://www.researchmoz.us/comentis-inc-product-pipeline-review-2015-report.html

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CoMentis, Inc. - Product Pipeline Review - 2015<br />

CoMentis, Inc. - Product Pipeline Review - 2015<br />

Summary<br />

Global Markets Directs, CoMentis, Inc. - Product Pipeline Review - 2015, provides an overview of the CoMentis, Inc.s pharmaceutical research and development<br />

focus.<br />

This report provides comprehensive information on the current therapeutic developmental pipeline of CoMentis, Inc.s, complete with comparative analysis at<br />

various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest<br />

updates, and featured news and press releases, along with special features on late-stage and discontinued projects.<br />

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built<br />

using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and<br />

featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug<br />

profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the<br />

latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that<br />

the most recent developments are captured on a real time basis.<br />

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by<br />

identifying new targets and MOAs to produce first-in-class and best-in-class products.<br />

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.<br />

Scope<br />

- The report provides brief overview of CoMentis, Inc. including business description, key information and facts, and its locations and subsidiaries<br />

- The report reviews current pipeline of CoMentis, Inc.s human therapeutic division and enlists all their major and minor projects<br />

- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major<br />

milestones<br />

- Special feature on out-licensed and partnered product portfolio<br />

- The report summarizes all the dormant and discontinued pipeline projects<br />

- Latest company statement<br />

- Latest news and deals relating to the CoMentis, Inc.s pipeline products<br />

Reasons to buy<br />

- Evaluate CoMentis, Inc.s strategic position with total access to detailed information on its product pipeline<br />

- Assess the growth potential of CoMentis, Inc. in its therapy areas of focus<br />

- Identify new drug targets and therapeutic classes in the CoMentis, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas<br />

- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps<br />

- Develop strategic initiatives by understanding the focus areas of CoMentis, Inc. and exploit collaboration and partnership opportunities<br />

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage<br />

- Plan mergers and acquisitions effectively by identifying the most promising pipeline of CoMentis, Inc.<br />

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand<br />

business potential and scope<br />

- Explore the dormant and discontinued projects of CoMentis, Inc. and identify potential opportunities in those areas<br />

- Avoid Intellectual Property Rights related issues<br />

Table Of Contents<br />

table Of Contents 2<br />

list Of Tables 3<br />

list Of Figures 3<br />

comentis, Inc. Snapshot 4<br />

comentis, Inc. Overview 4<br />

key Information 4<br />

key Facts 4<br />

comentis, Inc. - Research And Development Overview 5<br />

key Therapeutic Areas 5<br />

comentis, Inc. - Pipeline Review 7<br />

pipeline Products By Stage Of Development 7<br />

pipeline Products - Monotherapy 8<br />

comentis, Inc. - Pipeline Products Glance 9<br />

comentis, Inc. - Clinical Stage Pipeline Products 9<br />

phase Ii Products/combination Treatment Modalities 9<br />

CoMentis, Inc. - Product Pipeline Review - 2015


comentis, Inc. - Early Stage Pipeline Products 10<br />

preclinical Products/combination Treatment Modalities 10<br />

comentis, Inc. - Drug Profiles 11<br />

gts-21 11<br />

product Description 11<br />

mechanism Of Action 11<br />

r&d Progress 11<br />

grl-8234 13<br />

product Description 13<br />

mechanism Of Action 13<br />

r&d Progress 13<br />

small Molecules To Inhibit Beta Secretase For Alzheimer's Disease 14<br />

product Description 14<br />

mechanism Of Action 14<br />

r&d Progress 14<br />

comentis, Inc. - Pipeline Analysis 15<br />

comentis, Inc. - Pipeline Products By Target 15<br />

comentis, Inc. - Pipeline Products By Route Of Administration 16<br />

comentis, Inc. - Pipeline Products By Molecule Type 17<br />

comentis, Inc. - Pipeline Products By Mechanism Of Action 18<br />

comentis, Inc. - Dormant Projects 19<br />

comentis, Inc. - Locations And Subsidiaries 20<br />

head Office 20<br />

appendix 21<br />

methodology 21<br />

coverage 21<br />

secondary Research 21<br />

primary Research 21<br />

expert Panel Validation 21<br />

contact Us 21<br />

disclaimer 22<br />

list Of Tables<br />

comentis, Inc., Key Information 4<br />

comentis, Inc., Key Facts 4<br />

comentis, Inc. - Pipeline By Indication, 2015 6<br />

comentis, Inc. - Pipeline By Stage Of Development, 2015 7<br />

comentis, Inc. - Monotherapy Products In Pipeline, 2015 8<br />

comentis, Inc. - Phase Ii, 2015 9<br />

comentis, Inc. - Preclinical, 2015 10<br />

comentis, Inc. - Pipeline By Target, 2015 15<br />

comentis, Inc. - Pipeline By Route Of Administration, 2015 16<br />

comentis, Inc. - Pipeline By Molecule Type, 2015 17<br />

comentis, Inc. - Pipeline Products By Mechanism Of Action, 2015 18<br />

comentis, Inc. - Dormant Developmental Projects,2015 19<br />

list Of Figures<br />

comentis, Inc. - Pipeline By Top 10 Indication, 2015 6<br />

comentis, Inc. - Pipeline By Stage Of Development, 2015 7<br />

comentis, Inc. - Monotherapy Products In Pipeline, 2015 8<br />

comentis, Inc. - Pipeline By Top 10 Target, 2015 15<br />

comentis, Inc. - Pipeline By Top 10 Route Of Administration, 2015 16<br />

comentis, Inc. - Pipeline By Top 10 Molecule Type, 2015 17<br />

comentis, Inc. - Pipeline Products By Top 10 Mechanism Of Action, 2015 18<br />

ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your<br />

research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and<br />

across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an<br />

informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.<br />

Contact:<br />

Sales Team,<br />

90 State Street,<br />

Suite 700,<br />

Albany NY - 12207<br />

United States<br />

Tel: +1-518-618-1030<br />

USA - Canada Toll Free 866-997-4948<br />

CoMentis, Inc. - Product Pipeline Review - 2015


Email: sales@researchmoz.us<br />

Website: http://www.researchmoz.us/<br />

CoMentis, Inc. - Product Pipeline Review - 2015

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!